MarketPulse

license agreement

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Aligos Scores $25M Upfront in China Deal for Hepatitis B Drug

Aligos Therapeutics licenses pevifoscorvir to Xiamen Amoytop for Greater China development, receiving $25M upfront and up to $420M in milestones.
ALGSclinical developmentpevifoscorvir sodium
GlobeNewswire Inc.GlobeNewswire Inc.··Na

EssilorLuxottica Locks in Dolce&Gabbana Through 2050 in Major Strategic Extension

EssilorLuxottica extends Dolce&Gabbana eyewear license through 2050, reinforcing a two-decade partnership with a 25-year commitment to prescription frames and sunglasses distribution.
ESLOYpartnership extensioneyewear